In HFD-induced MASLD model, KD induced interleukin 6 (IL-6) production and thus activated c-Jun N-terminal kinase (JNK), which in turn inhibited insulin signal redirection, thereby preventing MASLD [60]. Here, MAPK8 is linked to metabolic dysfunction-associated steatotic liver disease.